Bruker (BRKRP) Shares Outstanding (Weighted Average) (2009 - 2026)
Bruker (BRKRP) reported Shares Outstanding (Weighted Average) of $152.2 million for Q1 2026, little changed on a YoY basis from $151.6 million in Q1 2025, and little changed quarter-over-quarter from $151.8 million in Q4 2025.
Bruker (BRKRP) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Bruker has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $152.2 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.4% year-over-year to $152.2 million; the trailing twelve-month figure through Mar 2026 stood at $152.2 million (changed 0.4% YoY), and the FY2025 full-year result was $151.8 million, up 1.88% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $152.2 million, roughly flat from $151.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $152.2 million in Q1 2026, with the low at $145.2 in Q1 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $79.6 million across 5 years, with a median of $146.4 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) slumped 100.0% — and 2025, when it jumped 104407613.5%.
- Bruker's Shares Outstanding (Weighted Average) stood at $148.6 in 2022, then soared by 98519415.48% to $146.4 million in 2023, then gained by 1.78% to $149.0 million in 2024, then climbed by 1.88% to $151.8 million in 2025, then increased by 0.26% to $152.2 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $152.2 million (Q1 2026), $151.8 million (Q4 2025), and $151.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Bruker | - | - | 379.80 Mn | 152.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 152.20 Mn |
| Dec 31, 2025 | 151.80 Mn |
| Sep 30, 2025 | 151.80 Mn |
| Jun 30, 2025 | 151.60 Mn |
| Mar 31, 2025 | 151.60 Mn |
| Dec 31, 2024 | 149.00 Mn |
| Sep 30, 2024 | 151.50 Mn |
| Jun 30, 2024 | 147.40 Mn |
| Mar 31, 2024 | 145.20 |
| Dec 31, 2023 | 146.40 Mn |
| Sep 30, 2023 | 146.60 |
| Jun 30, 2023 | 146.80 |
| Mar 31, 2023 | 146.80 |
| Dec 31, 2022 | 148.60 |
| Sep 30, 2022 | 147.80 |
| Jun 30, 2022 | 149.70 |
| Mar 31, 2022 | 150.40 |
| Dec 31, 2021 | 151.40 |
| Sep 30, 2021 | 151.40 |
| Jun 30, 2021 | 151.30 |